Is Addyi worth the risk?

ADDYI is the “Viagra for women” –or so they say. The FDA recently approved Addyi (Flibanserin) for treatment of hypoactive sexual desire disorder in premenopausal women. It is estimated that 40-50 percent of women have some sort of sexual dysfunction and this is the first medication the FDA has approved for this type of issue. Addyi is actually a failed antidepressant and acts on neurotransmitter receptors in the brain, although the exact mechanism of action is unknown.

Read More